Viewing Study NCT06355934


Ignite Creation Date: 2025-12-25 @ 2:21 AM
Ignite Modification Date: 2025-12-28 @ 12:04 AM
Study NCT ID: NCT06355934
Status: RECRUITING
Last Update Posted: 2025-12-15
First Post: 2024-02-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: OverTTuRe: Characteristics, Treatment Patterns and Outcomes of Patients With ATTR Amyloidosis
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module